Johnson Winter Slattery (JWS) has assisted three of the lead investors in AdvanCell’s US$112m Series C financing effort.

Plus: South Korea stockpiles AI chips and shuts out DeepSeek; OPEC+ reportedly mulling delay to April supply increase; European stocks soar as war fears fuel defence rally.

Brisbane-based AdvanCell raised $178 million in one of the biggest funding rounds of 2025 so far. It's good news for an ...

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where Eli ...